Works matching IS 13524585 AND DT 2016 AND VI 22 AND IP 7

Results: 21

All relapsing multiple sclerosis patients should be managed at a specialist clinic – Commentary.

Published in:

2016

By:

Hutchinson, Michael

Publication type:

Opinion

Leptomeningeal enhancement in Susac’s syndrome and multiple sclerosis: Time to expect the unexpected?

Published in:

Multiple Sclerosis Journal, 2016, v. 22, n. 7, p. 975, doi. 10.1177/1352458516644677

By:

Sastre-Garriga, Jaume

Publication type:

Article

The N-MOmentum trial: Building momentum to advance trial methodology in a rare disease.

Published in:

Multiple Sclerosis Journal, 2016, v. 22, n. 7, p. 852, doi. 10.1177/1352458516643399

By:

Chataway, Jeremy;
Friede, Tim

Publication type:

Article

All relapsing multiple sclerosis patients should be seen in specialist clinics – NO.

Published in:

Multiple Sclerosis Journal, 2016, v. 22, n. 7, p. 875, doi. 10.1177/1352458516642855

By:

Brenner, Robert

Publication type:

Article

Susac’s syndrome: Leptomeningeal enhancement on 3D FLAIR MRI.

Published in:

2016

By:

Engisch, Renate;
Titelbaum, David S.;
Chilver-Stainer, Lara;
Kellner-Weldon, Frauke

Publication type:

Case Study

All relapsing multiple sclerosis patients should be managed at a specialist clinic – YES.

Published in:

Multiple Sclerosis Journal, 2016, v. 22, n. 7, p. 873, doi. 10.1177/1352458516636474

By:

Brownlee, Wallace J.;
Ciccarelli, Olga

Publication type:

Article

Urinary tract infections in multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2016, v. 22, n. 7, p. 855, doi. 10.1177/1352458516633903

By:

Phé, Véronique;
Pakzad, Mahreen;
Curtis, Carmel;
Porter, Bernadette;
Haslam, Collette;
Chataway, Jeremy;
Panicker, Jalesh N.

Publication type:

Article

Extensive molluscum contagiosum virus infection in a young adult receiving fingolimod.

Published in:

2016

By:

Behle, Valeria;
Wobser, Marion;
Goebeler, Matthias;
Stoevesandt, Johanna

Publication type:

Case Study

Placebo-controlled study in neuromyelitis optica—Ethical and design considerations.

Published in:

Multiple Sclerosis Journal, 2016, v. 22, n. 7, p. 862, doi. 10.1177/1352458515620934

By:

Cree, Bruce A. C.;
Bennett, Jeffrey L.;
Sheehan, Mark;
Cohen, Jeffrey;
Hartung, Hans-Peter;
Aktas, Orhan;
Kim, Ho Jin;
Paul, Friedemann;
Pittock, Sean;
Weinshenker, Brian;
Wingerchuk, Dean;
Fujihara, Kazuo;
Cutter, Gary;
Patra, Kaushik;
Flor, Armando;
Barron, Gerard;
Madani, Soraya;
Ratchford, John N.;
Katz, Eliezer

Publication type:

Article

The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients.

Published in:

Multiple Sclerosis Journal, 2016, v. 22, n. 7, p. 964, doi. 10.1177/1352458515614093

By:

Siritho, Sasitorn;
Sato, Douglas K.;
Kaneko, Kimihiko;
Fujihara, Kazuo;
Prayoonwiwat, Naraporn

Publication type:

Article

Spinal cord involvement in Behçet’s disease.

Published in:

Multiple Sclerosis Journal, 2016, v. 22, n. 7, p. 960, doi. 10.1177/1352458515613642

By:

Lee, Hyung Seok;
Kim, Do Young;
Shin, Ha Young;
Choi, Young-Chul;
Kim, Seung Min

Publication type:

Article

Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study.

Published in:

Multiple Sclerosis Journal, 2016, v. 22, n. 7, p. 901, doi. 10.1177/1352458515607650

By:

Tillema, J. M.;
Hulst, H. E.;
Rocca, M. A.;
Vrenken, H.;
Steenwijk, M. D.;
Damjanovic, D.;
Enzinger, C.;
Ropele, S.;
Tedeschi, G.;
Gallo, A.;
Ciccarelli, O.;
Rovira, A.;
Montalban, X.;
de Stefano, N.;
Stromillo, M. L.;
Filippi, M.;
Barkhof, F.

Publication type:

Article

Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine.

Published in:

Multiple Sclerosis Journal, 2016, v. 22, n. 7, p. 944, doi. 10.1177/1352458515606809

By:

Macdonell, Richard;
Nagels, Guy;
Laplaud, David-Axel;
Pozzilli, Carlo;
de Jong, Brigit;
Martins da Silva, Ana;
Nicholas, Richard;
Lechner-Scott, Jeannette;
Gaebler, Julia A.;
Agarwal, Sonalee;
Wang, Ping;
Yeh, Michael;
Hovenden, Maria;
Soelberg Sørensen, Per

Publication type:

Article

Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort.

Published in:

Multiple Sclerosis Journal, 2016, v. 22, n. 7, p. 935, doi. 10.1177/1352458515606211

By:

Bove, Riley;
Healy, Brian C.;
Musallam, Alexander;
Glanz, Bonnie I.;
De Jager, Philip L.;
Chitnis, Tanuja

Publication type:

Article

Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2016, v. 22, n. 7, p. 926, doi. 10.1177/1352458515605908

By:

Ratzer, Rikke;
Iversen, Pernille;
Börnsen, Lars;
Dyrby, Tim B.;
Romme Christensen, Jeppe;
Ammitzbøll, Cecilie;
Madsen, Camilla Gøbel;
Garde, Ellen;
Lyksborg, Mark;
Andersen, Birgit;
Hyldstrup, Lars;
Sørensen, Per Soelberg;
Siebner, Hartwig R.;
Sellebjerg, Finn

Publication type:

Article

Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2016, v. 22, n. 7, p. 910, doi. 10.1177/1352458515604905

By:

Kearney, Hugh;
Miszkiel, Katherine A.;
Yiannakas, Marios C.;
Altmann, Daniel R.;
Ciccarelli, Olga;
Miller, David H.

Publication type:

Article

Optical coherence tomography indicates disease activity prior to clinical onset of central nervous system demyelination.

Published in:

Multiple Sclerosis Journal, 2016, v. 22, n. 7, p. 893, doi. 10.1177/1352458515604496

By:

Knier, Benjamin;
Berthele, Achim;
Buck, Dorothea;
Schmidt, Paul;
Zimmer, Claus;
Mühlau, Mark;
Hemmer, Bernhard;
Korn, Thomas

Publication type:

Article

Lymphocytosis as a response biomarker of natalizumab therapeutic efficacy in multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2016, v. 22, n. 7, p. 921, doi. 10.1177/1352458515604381

By:

Signoriello, E.;
Lanzillo, R.;
Brescia Morra, V.;
Di Iorio, G.;
Fratta, M.;
Carotenuto, A.;
Lus, G.

Publication type:

Article

Higher intake of omega-3 polyunsaturated fatty acids is associated with a decreased risk of a first clinical diagnosis of central nervous system demyelination: Results from the Ausimmune Study.

Published in:

Multiple Sclerosis Journal, 2016, v. 22, n. 7, p. 884, doi. 10.1177/1352458515604380

By:

Hoare, Samuel;
Lithander, Fiona;
van der Mei, Ingrid;
Ponsonby, Anne-Louise;
Lucas, Robyn;
Chapman, Caron;
Coulthard, Alan;
Dear, Keith;
Dwyer, Terry;
Kilpatrick, Trevor;
Lucas, Robyn M.;
McMichael, Tony;
Pender, Michael P.;
Taylor, Bruce;
Valery, Patricia C.;
Williams, David

Publication type:

Article

Body mass index during adolescence, rather than childhood, is critical in determining MS risk.

Published in:

Multiple Sclerosis Journal, 2016, v. 22, n. 7, p. 878, doi. 10.1177/1352458515603798

By:

Hedström, A. K.;
Olsson, T.;
Alfredsson, L.

Publication type:

Article

Efficacy of rituximab in refractory neuromyelitis optica.

Published in:

Multiple Sclerosis Journal, 2016, v. 22, n. 7, p. 955, doi. 10.1177/1352458515602337

By:

Collongues, N.;
Brassat, D.;
Maillart, E.;
Labauge, P.;
Ouallet, J. C.;
Carra-Dalliere, C.;
Moreau, T.;
Bourre, B.;
Papeix, C.;
Brochet, B.;
Audoin, B.;
Vukusic, S.;
de Seze, J.;
Marignier, R.

Publication type:

Article